Answer Capsule
Corebridge Financial Final Expense life insurance is a mixed fit for a senior with heart conditions seeking $15,000–$25,000 of permanent coverage. Two of the five platforms that evaluated fit named Corebridge during the ranking stage, giving it a 40% share of included platform responses, an average listed rank of 4.5, and a best listed rank of 3. The strongest reason to consider it is that Corebridge offers both a simplified-issue pathway (SimpliNow Legacy) and a guaranteed-issue whole life pathway, which may help applicants whose cardiac history complicates fully underwritten coverage. The main limitation is that no reviewed source documents Corebridge's diagnosis-specific cardiac underwriting, and the two-year limited-benefit period reduces protection if death occurs soon after issue.
Research Snapshot
| Field | Finding |
|---|---|
| Platform mentions in ranking stage | 2 of 5 included platforms (openai, perplexity) |
| Share of included platform responses | 40% |
| Average listed rank | 4.5 |
| Best listed rank | 3 |
| Relevant product/model/plan | Final Expense Whole Life, particularly SimpliNow Legacy or Guaranteed Issue Whole Life Insurance |
| Overall use-case fit | Mixed |
| Research date | 2026-09-22 |
Why Corebridge Financial Final Expense Life Insurance Qualified for This Study
Questions This Section Answers
- Why did Corebridge Financial Final Expense Life Insurance qualify for this final expense insurance study for people with heart conditions?
- Is Corebridge Financial Final Expense Life Insurance a good choice for a senior with heart conditions who needs $15,000 to $25,000 of permanent coverage?
Corebridge qualified because it markets permanent final-expense whole life products that map directly onto the buyer's request, and because two platforms named it during ranking discovery. Corebridge identifies Final Expense Whole Life as coverage for seniors and for expenses such as funeral costs, medical bills, and credit-card bills, with SimpliNow Legacy and Guaranteed Issue Whole Life Insurance as the listed relevant products [1]. The product category is whole life insurance, intended to provide ongoing death-benefit protection rather than temporary term coverage [1].
The company also offers both a simplified-issue pathway and a guaranteed-issue pathway, which is the structural reason it appears in a heart-condition study at all. SimpliNow Legacy is described as simplified-issue whole life insurance with no medical exam, limited early benefits, 110% of premiums paid during the first two years, and underwriting-based eligibility [2]. Corebridge separately lists Guaranteed Issue Whole Life Insurance [1]. Corebridge Financial is also a large U.S. insurance and retirement organization with publicly available corporate information from the SEC and its own disclosures, which supports basic legitimacy but does not by itself confirm cardiac underwriting outcomes or pricing competitiveness [3].
Qualification for this study is not an endorsement. The ranking stage counted only platforms that named the entity during discovery, and all five included platforms evaluated fit regardless of whether they named Corebridge in ranking. This review sits inside the broader Final Expense Insurance for People With Heart Conditions consensus study, which compares multiple carriers against the same buyer profile.
The Product, Model, Plan, or Service Most Relevant to Final Expense Insurance for People With Heart Conditions
Questions This Section Answers
- Which Corebridge Financial Final Expense Life Insurance plan should a buyer with heart conditions choose if they need $15,000 to $25,000 of permanent coverage?
- Does Corebridge Financial SimpliNow Legacy or Guaranteed Issue Whole Life Insurance accept applicants with a history of heart attack, stents, or bypass surgery?
The most relevant Corebridge products for this buyer are Final Expense Whole Life, sold as either SimpliNow Legacy (simplified issue) or Guaranteed Issue Whole Life Insurance [5]. All five included platforms converged on this same product pairing, which is the clearest point of agreement in the study.
SimpliNow Legacy is the simplified-issue route. Corebridge describes it as simplified-issue whole life insurance with no medical exam, limited early benefits, 110% of premiums paid during the first two years, and underwriting-based eligibility [6]. Corebridge advertises a fast application without a medical exam and underwriting decisions in minutes in one meeting for the final-expense offering [5]. That speed may be useful for a senior with heart-related medical history, but it does not mean acceptance is guaranteed for SimpliNow Legacy.
Guaranteed Issue Whole Life Insurance is the fallback route. Corebridge Direct says guaranteed issue whole life is a form of final expense insurance, offers $5,000 to $25,000 in coverage, no medical exam or health questions, and is available to ages 50 to 80 [11]. Independent reviews describe the same structure: no health questions, no exam, ages 50 to 80, $5,000 to $25,000 coverage, and a two-year graded death benefit [12]. One independent 2025 review says SimpliNow Legacy has $5,000 to $35,000 coverage, with a limited first-two-years benefit on one version and guaranteed issue available from $5,000 to $25,000 for ages 50 to 80 [13]. Another independent review states Corebridge's whole life options include simplified issue final expense up to $35,000 and guaranteed issue up to $25,000, with a two-year graded benefit on guaranteed issue [14].
For the buyer's $15,000–$25,000 target, the guaranteed-issue ceiling of $25,000 sits exactly at the top of the requested range, and the simplified-issue ceiling of $35,000 would cover it if that figure is accurate. However, the reviewed public materials do not confirm that $15,000–$25,000 face amounts are available for this product, applicant age, state, and medical profile [5]. Policies are issued by American General Life Insurance Company, except in New York where The United States Life Insurance Company in the City of New York issues them, and products and features may not be available in all states [6].
What the AI Platforms Agreed About
Questions This Section Answers
- What do AI platforms agree on about Corebridge Financial Final Expense Life Insurance for buyers with heart conditions?
- Does Corebridge Financial Final Expense Life Insurance offer both simplified-issue and guaranteed-issue options for seniors with cardiac history?
The platforms agreed on product structure and on the core limitation. All five included platforms identified the same two relevant products — SimpliNow Legacy and Guaranteed Issue Whole Life Insurance — as the Corebridge options that matter for a senior with heart conditions [15].
They also agreed that the two-year limited-benefit period is a real drawback. Corebridge states that death during the first two years results in a benefit equal to 110% of premiums paid, and that SimpliNow Legacy otherwise offers the full policy amount in all years after that period [15]. Independent summaries describe the same structure: years 1–2 return of premiums plus 10%, year 3 and later full face amount [24], and a two-year graded benefit on guaranteed issue [25]. Grok's response describes graded benefits in years 1–2 at 110% of premiums paid with full benefit from year 3 [27].
A third area of agreement is that public cardiac underwriting detail is missing. OpenAI found that the reviewed Corebridge materials do not disclose whether particular heart diagnoses, cardiac procedures, medications, or time since an event receive standard, modified, graded, or declined offers [15]. DeepSeek found that public Corebridge pages do not clearly publish the specific cardiac underwriting criteria used to approve or rate simplified-issue final expense applicants [17]. Perplexity found that Corebridge materials state some products are subject to underwriting, but publicly available pages do not clearly publish diagnosis-specific heart-condition knockouts, waiting rules by diagnosis, or medication-specific guidelines [20]. Kimi found that no independent source documents Corebridge's specific tier placements for cardiac conditions [23].
Agreement among platforms reflects shared reliance on the same public disclosures, not independent verification of product quality.
Where the AI Platforms Disagreed or Were Uncertain
Questions This Section Answers
- Do AI platforms disagree about whether Corebridge Financial Final Expense Life Insurance is a good fit for heart-condition applicants?
- Is Corebridge Financial Final Expense Life Insurance better than CICA Life or Gerber Life for a senior with congestive heart failure or a recent cardiac event?
The platforms split on overall fit rating. Grok rated Corebridge a "good" fit, citing favorable underwriting for heart conditions in life insurance and tiered simplified/guaranteed options [33]. OpenAI, DeepSeek, and Perplexity each rated it "mixed" (openai, deepseek, perplexity). Kimi rated it "uncertain," stating that Corebridge's final expense offerings for people with heart conditions cannot be adequately assessed from publicly available information (kimi).
The sharpest disagreement concerns coverage limits. Perplexity flagged that public sources conflict on the exact simplified-issue maximum: some describe SimpliNow Legacy up to $35,000, while Corebridge pages surfaced in search results also emphasize smaller final-expense ranges and guaranteed-issue coverage up to $25,000 [35]. Grok reported SimpliNow Legacy at $5,000–$35,000 simplified issue and GIWL at $5,000–$25,000 guaranteed issue for ages 50–80 [38]. This conflict is unresolved in the supplied evidence and should be verified directly with the carrier.
Pricing evidence is thin and inconsistent. Perplexity found that Corebridge Direct says guaranteed issue premiums start at $22 per month for $5,000 of coverage, with rates varying by issue age, gender, and coverage amount [40]. No other platform found a published Corebridge rate for a heart-condition applicant. Kimi supplied market benchmarks rather than Corebridge-specific pricing: level day-one $45–$65/month at age 65 for $10,000; simplified modified $55–$80/month; graded $65–$100/month; guaranteed issue $80–$130/month, while stating Corebridge's placement within these tiers is unknown (kimi). Those benchmarks are platform-reported and not Corebridge-specific.
Maximum issue age is also unresolved. Kimi noted that Corebridge's maximum issue age for final expense products is not stated in publicly available sources reviewed, while Aetna/Accendo accepts to 89, Mutual of Omaha and Transamerica to 85, and Aflac caps at 80 [41]. One Corebridge-owned page states guaranteed issue availability to ages 50 to 80 [40], but the reviewed materials do not establish age eligibility for every product version.
A factual conflict also appears in Corebridge's own materials. Corebridge's financial-professional page uses the phrase "guaranteed protection for seniors," while the consumer material states that SimpliNow Legacy coverage is subject to underwriting; the wording appears to refer to the overall final-expense category or guaranteed-issue product, not guaranteed acceptance for SimpliNow Legacy (openai). Buyers should not read "guaranteed protection" as guaranteed acceptance.
Use-Case-Specific Features and Capabilities
Questions This Section Answers
- What features of Corebridge Financial Final Expense Life Insurance matter most for a senior with heart conditions?
- Does Corebridge Financial Final Expense Life Insurance include accelerated death benefits, and how do they affect the remaining death benefit?
The features most relevant to a heart-condition buyer are the no-exam application, the dual simplified/guaranteed pathway, permanent whole life structure, and accelerated death-benefit riders. Corebridge advertises accelerated death-benefit riders at no additional cost on the final-expense page, but rider eligibility, qualifying events, advance limits, state availability, and the effect on the remaining death benefit must be confirmed in the policy documents [42]. Corebridge describes accelerated death-benefit rider operation, including that accelerated payments reduce death benefits and policy values and are not a replacement for long-term-care insurance [43].
Corebridge states that this is not a preneed contract and that benefits are payable to the policy beneficiary or beneficiaries, which may provide more flexibility than a funeral-home-specific arrangement, subject to the contract [44].
On the underwriting side, the capability that matters most is the guaranteed-issue fallback. Guaranteed issue is the clearest fit for applicants with significant cardiac history because no health questions are required; however, public sources do not verify exact acceptance rules for specific heart diagnoses under simplified issue [45]. Kimi noted that CICA Life is documented as the only carrier that sometimes approves managed CHF at level (day-one) rates, while most carriers relegate CHF to guaranteed issue, and Corebridge's CHF policy is not independently described [48]. That is a comparative gap, not a Corebridge feature.
Corebridge warns that premiums paid may exceed the amount of coverage and provides no public quote on the reviewed pages [44]. This matters when comparing guaranteed-issue premiums with simplified-issue alternatives.
Pricing, Fees, Contracts, and Ongoing Costs
Questions This Section Answers
- How much does Corebridge Financial Final Expense Life Insurance cost per month for a senior with heart conditions, and are there policy fees?
- What are the contract terms, graded-benefit period, and cancellation provisions of Corebridge Financial Final Expense Life Insurance?
No public premium quote, rate table, face-amount range, age limit, or cardiac-risk pricing was found on the reviewed official pages, so pricing confidence is low across every platform that reported on it (openai, deepseek, perplexity, grok, kimi). The only concrete Corebridge price point in the supplied evidence is that guaranteed issue whole life premiums start at $22 per month for $5,000 of coverage, according to Corebridge Direct, with rates varying by issue age, gender, and coverage amount [50]. That figure is for the smallest guaranteed-issue face amount and does not indicate what a $15,000–$25,000 policy would cost a buyer with cardiac history.
On fees, OpenAI found no separate application fee or policy fee identified in the reviewed materials, but noted that any policy charges, rider charges, modal-payment charges, or state-specific costs are unclear and should be confirmed in the illustration and policy contract (openai). DeepSeek noted possible policy fees, modal premium fees, or state-specific charges may apply but were not clearly enumerated in sources reviewed (deepseek). Perplexity found no separate fee schedule in the public sources reviewed (perplexity).
On contract terms, the first two years have a limited death benefit for SimpliNow Legacy and Guaranteed Issue Whole Life Insurance, and suicide provisions limit the benefit to a refund of premiums paid less outstanding loan amounts, according to the reviewed Corebridge materials [51]. Products and features may vary by state, and exact free-look, lapse, reinstatement, loan, surrender, and nonforfeiture terms were not stated on the reviewed pages (openai). Corebridge warns that total premiums may exceed the policy's face amount, and that if an accelerated death-benefit rider is used, the death benefit and potentially policy values are reduced [51].
Kimi supplied industry benchmark ranges rather than Corebridge rates: level day-one $45–$65/month at age 65 for $10,000; simplified modified $55–$80/month; graded $65–$100/month; guaranteed issue $80–$130/month (kimi). These are platform-reported market benchmarks, not Corebridge quotes, and should not be treated as Corebridge pricing.
Best Suited For
Questions This Section Answers
- Who is Corebridge Financial Final Expense Life Insurance best suited for among seniors with heart conditions?
- Is Corebridge Financial Final Expense Life Insurance worth it for a buyer whose heart condition is mild, well controlled, or distant in history?
Corebridge is best suited for a senior seeking permanent coverage for funeral, medical, credit-card, or other final expenses; a buyer whose heart condition may qualify for simplified underwriting and who values a rapid, no-exam application; and a buyer who cannot qualify for traditionally underwritten coverage and is willing to accept a two-year limited-benefit structure if eligible for Guaranteed Issue Whole Life (openai). DeepSeek framed the best-fit buyer as a senior with mild, well-controlled, or distant-history heart conditions who may qualify for simplified-issue coverage without a medical exam, plus buyers who want a named permanent whole life final expense product with simplified or guaranteed issue underwriting (deepseek). Perplexity framed it as seniors ages 50 to 80 seeking permanent final expense coverage with no-exam or simplified-issue pathways, buyers who may qualify for simplified issue and want coverage in the $5,000 to $35,000 range, and buyers with more serious health history who may need guaranteed-issue coverage up to $25,000 (perplexity).
Grok's best-fit framing was narrower on age and coverage: seniors 50–80 with controlled or recovered heart conditions seeking $5,000–$35,000 whole life coverage, and buyers needing no-medical-exam options with possible living benefits for chronic or terminal illness (grok). Kimi's best-fit framing was the most cautious: buyers who can complete full underwriting disclosure with a licensed agent to determine actual eligibility, and those who want to compare a large financial institution's guaranteed issue option against Gerber Life and AIG equivalents (kimi).
The common thread across platforms is that Corebridge fits buyers whose cardiac history is stable enough for simplified issue, or who accept graded benefits through guaranteed issue. It is a comparison candidate, not a default selection.
Probably Not Best Suited For
Questions This Section Answers
- Who should not choose Corebridge Financial Final Expense Life Insurance for final expense coverage with a heart condition?
- Is Corebridge Financial Final Expense Life Insurance a poor choice for a buyer with a recent heart attack or unstable cardiac disease?
Corebridge is probably not best for a buyer needing certainty that $15,000–$25,000 is available at an affordable premium; a buyer with a recent heart attack, major cardiac surgery, unstable disease, or high near-term mortality risk who needs full death-benefit protection immediately; and a buyer comparing multiple carriers specifically for cardiac underwriting, because Corebridge does not publicly disclose diagnosis-specific acceptance criteria on the reviewed pages (openai).
DeepSeek added seniors with recent heart attack, unstable angina, recent stent or bypass, or advanced heart failure who need guaranteed acceptance with minimal health questions and accept graded benefits; buyers seeking the lowest possible premium for a specific cardiac history who should compare multiple carriers' simplified-issue underwriting guidelines; and buyers who need immediate full death benefit despite severe cardiac history (deepseek). Perplexity added buyers who need clearly published underwriting rules for heart conditions before applying, buyers wanting coverage above the small final-expense range, and buyers who cannot accept a graded-benefit period or limited early death benefit on some policies (perplexity). Grok added those seeking immediate full level benefit without any graded period, and applicants preferring online instant quotes without agent involvement (grok). Kimi added buyers seeking immediate independent verification of heart-condition underwriting competitiveness, those with managed CHF, cardiomyopathy, or post-stroke histories where CICA Life offers documented level-rate possibilities, and seniors over 80 seeking guaranteed issue (kimi).
When Another Option May Be Better
Questions This Section Answers
- What is a better alternative to Corebridge Financial Final Expense Life Insurance for a buyer with congestive heart failure or a recent cardiac event?
- When should a buyer choose a different carrier instead of Corebridge Financial Final Expense Life Insurance for heart-condition underwriting?
Another carrier is better when it publicly demonstrates more favorable underwriting for the buyer's exact cardiac diagnosis, treatment history, medications, and time since the last event (openai). A guaranteed-issue carrier is better when simplified underwriting declines the applicant, provided the buyer accepts graded benefits and verifies that the requested face amount is available (openai). A medically underwritten whole-life carrier is better when the applicant's heart condition is stable and standard or better-than-guaranteed underwriting can produce materially lower premiums (openai). A broker comparing multiple final-expense carriers is better when the buyer needs an actual $15,000–$25,000 quote and side-by-side cardiac underwriting outcomes (openai).
Kimi named specific alternatives with documented positioning: CICA Life for managed CHF, cardiomyopathy, stroke/TIA, or dialysis, where it may offer level day-one rates; Transamerica for complex paired conditions such as insulin-dependent diabetes with heart disease; Mutual of Omaha for lowest premium among simplified-issue qualifiers; Aetna/Accendo for ages 81–89 guaranteed issue; and Gerber Life for applicants currently hospitalized, using oxygen, or needing ADL help [54]. Those comparisons are platform-reported and were not independently verified in this study.
Perplexity framed the alternative trigger as needing a published underwriting guide that clearly addresses heart attacks, stents, bypass surgery, CHF, arrhythmias, or ongoing cardiac medications (perplexity). Grok framed it as needing immediate full level benefit without grading, or having milder conditions where other carriers may offer better simplified rates (grok). Buyers comparing across the broader life insurance market should treat Corebridge as one quote among several.
Questions to Verify Before Buying
Questions This Section Answers
- What should a buyer confirm with Corebridge Financial Final Expense Life Insurance before signing a contract for heart-condition coverage?
- How can a buyer verify Corebridge Financial Final Expense Life Insurance cardiac underwriting, face amount, and premium before paying?
For the applicant's state and age, confirm whether SimpliNow Legacy or Guaranteed Issue Whole Life is available, and whether the policy can provide exactly $15,000–$25,000, including minimum and maximum face amounts (openai). Ask how the applicant's exact diagnosis, last cardiac event, surgeries or stents, ejection fraction, medications, hospitalizations, and current stability would be classified, and whether the offer would be preferred, standard, rated, modified, graded, guaranteed issue, or declined (openai).
Confirm the exact death benefit if death occurs during each of the first two policy years and when the full face amount begins, plus the monthly or annual premium, whether it is level for life, and the total projected premium paid at ages 75, 85, and 95 (openai). Ask about policy fees, modal-payment charges, rider charges, or state-specific costs, and about free-look, lapse, reinstatement, surrender, loan, and nonforfeiture provisions (openai).
Confirm which accelerated death-benefit riders are included, what qualifies, how much can be accelerated, and how use affects the beneficiary's remaining benefit; which legal issuing company will issue the policy and whether quoted guarantees rest on that company's claims-paying ability; and whether a personalized illustration and complete policy form can be reviewed before paying or replacing existing coverage [58].
DeepSeek added verifying the exact cardiac underwriting questions and criteria for SimpliNow Legacy, whether guaranteed issue is available in the buyer's state and age, the graded-benefit period and benefit schedule, the exact premium including any policy fees, the free-look period, and how Corebridge's rate and underwriting compare with other simplified-issue and guaranteed-issue carriers (deepseek). Perplexity added confirming whether the chosen policy is level or graded benefit, how long any graded period lasts, whether any waiting period extends beyond the graded-benefit provision, and whether benefits and exclusions are identical across Corebridge, American General, and Corebridge Direct-branded offerings (perplexity). Kimi added confirming the maximum issue age for the specific product, whether treatment or medication is required to qualify for simplified issue, whether hospitalization or oxygen-use restrictions force guaranteed issue, and the AM Best rating for the issuing legal entity (kimi).
Final AI Consensus Verdict
Corebridge Financial Final Expense Life Insurance is a mixed fit for a senior with heart conditions seeking $15,000–$25,000 of permanent final expense coverage. It has relevant permanent final-expense products and a potentially useful no-exam simplified-issue route, plus a guaranteed-issue alternative. For this buyer, however, the public evidence is insufficient to establish favorable cardiac underwriting, affordable premiums, or availability of the target amount. The two-year limited-benefit period makes the offering less attractive when immediate full protection is essential. It should be considered through a multi-carrier quote comparison rather than selected as the default best option.
How This Review Was Produced
This review was produced from five included platform responses that evaluated Corebridge Financial Final Expense Life Insurance for the final expense insurance for people with heart conditions use case. Two of those five platforms named Corebridge during the ranking stage, producing a 40% share of included platform responses, an average listed rank of 4.5, and a best listed rank of 3. Fit ratings split across platforms: Grok rated the fit "good," OpenAI, DeepSeek, and Perplexity rated it "mixed," and Kimi rated it "uncertain." The study research date is 2026-09-22. All factual claims are cited to supplied platform-reported evidence, and company-owned sources are distinguished from independent sources throughout.
Methodology Limitations
Several limitations apply. The public materials do not provide diagnosis-specific cardiac underwriting rules, so qualification and rating for a specific cardiac history are uncertain without direct application or agent review (openai, deepseek). The simplified-issue product is not guaranteed acceptance and may decline or modify applicants based on underwriting (openai). The two-year limited-benefit period can materially reduce protection if death occurs soon after issue (openai, perplexity). The public materials do not confirm that the requested $15,000–$25,000 amount is available for this buyer (openai, deepseek). No public prices were found, preventing a meaningful affordability comparison (openai, deepseek, perplexity, grok, kimi). State availability, age limits, face-amount limits, exclusions, and policy-form details may vary (openai, perplexity).
The assessment relies primarily on Corebridge's own product disclosures; independent evidence comparing its cardiac underwriting, approval rates, premiums, or customer outcomes was not identified (openai). Public sources conflict on the exact simplified-issue maximum coverage, with some describing SimpliNow Legacy up to $35,000 and others emphasizing smaller ranges and guaranteed-issue coverage up to $25,000 [59]. It is unclear whether the cited campaign URL remains the current official product page or whether product names and features have changed (deepseek). Third-party descriptions of Corebridge final expense products may not reflect current underwriting or rates (deepseek).
Platform-reported research dates differ from the authoritative run date: DeepSeek reported 2026-06-01, while Grok, Kimi, OpenAI, and Perplexity reported 2026-09-22. Platform-reported dates are provenance metadata and do not independently prove freshness. DeepSeek's response was produced with search disabled, so its claims require explicit verification before being described as current facts. The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Citations are platform-reported evidence, not independently verified facts. The ranking stage counted only platforms that named the entity during discovery; all included platforms evaluated fit regardless of whether they named Corebridge in ranking. Agreement among platforms reflects shared reliance on the same public disclosures, not independent verification of product quality.
Sources
Company-Owned Sources
- Final Expense Life Insurance for Seniors: https://www.corebridgedirect.com/final-expense-insurance
- Corebridge Financial Official Website: https://www.corebridgefinancial.com
- Corebridge Financial Guaranteed Issue Whole Life Insurance: https://www.corebridgefinancial.com/guaranteed-issue-whole-life
- Help cover your expenses and protect your legacy with SimpliNow Legacy: https://www.corebridgefinancial.com/insights-education/dont-leave-your-debt-behind
- Corebridge Financial SimpliNow Legacy: https://www.corebridgefinancial.com/simplinow-legacy
- Final expense whole life insurance: https://www.corebridgefinancial.com/what-we-offer/life-insurance/final-expense-whole-life-insurance
- Permanent Life Insurance | Corebridge Financial - Individual: https://www.corebridgefinancial.com/what-we-offer/life-insurance/permanent-life-insurance
Additional AI research evidence61 records
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record deepseek:c4
- AI research evidence record deepseek:c5
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record deepseek:c1
- AI research evidence record deepseek:c2
- AI research evidence record deepseek:c3
- AI research evidence record perplexity:c1
- AI research evidence record perplexity:c2
- AI research evidence record perplexity:c10
- AI research evidence record perplexity:c4
- AI research evidence record perplexity:c7
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record deepseek:c1
- AI research evidence record deepseek:c2
- AI research evidence record deepseek:c3
- AI research evidence record perplexity:c1
- AI research evidence record perplexity:c2
- AI research evidence record grok:10
- AI research evidence record kimi:corebridge_site
- AI research evidence record perplexity:c11
- AI research evidence record perplexity:c7
- AI research evidence record perplexity:c10
- AI research evidence record grok:0
- AI research evidence record perplexity:c8
- AI research evidence record perplexity:c9
- AI research evidence record kimi:asurgo_heart
- AI research evidence record kimi:theburialinsurance_chf
- AI research evidence record kimi:cica_review
- AI research evidence record grok:0
- AI research evidence record grok:3
- AI research evidence record perplexity:c4
- AI research evidence record perplexity:c7
- AI research evidence record perplexity:c13
- AI research evidence record grok:2
- AI research evidence record grok:10
- AI research evidence record perplexity:c2
- AI research evidence record kimi:aflac_review
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record openai:c1
- AI research evidence record perplexity:c2
- AI research evidence record perplexity:c9
- AI research evidence record perplexity:c10
- AI research evidence record kimi:theburialinsurance_chf
- AI research evidence record kimi:cica_review
- AI research evidence record perplexity:c2
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record kimi:theburialinsurance_chf
- AI research evidence record kimi:cica_review
- AI research evidence record kimi:fexguy_heart
- AI research evidence record kimi:aflac_review
- AI research evidence record openai:c3
- AI research evidence record perplexity:c4
- AI research evidence record perplexity:c7
- AI research evidence record perplexity:c13
Independent Sources
- Aflac Final Expense Review 2026 - Rates by Age: https://asurgo.com/insurance-reviews/aflac
- Final Expense Insurance With Heart Disease - 2026 Guide: https://asurgo.com/life-insurance-for/heart-disease
- Heart Conditions Burial Insurance - Get Day 1 Coverage: https://fexguy.com/burial-insurance/heart-conditions/
- Corebridge (formerly AIG) Guaranteed Issue Whole Life Review: https://guaranteedlifeinsured.com/corebridge-aig-guaranteed-issue-review/
- Burial Insurance With Congestive Heart Failure (2026): Your Options: https://theburialinsurance.com/burial-insurance-with-congestive-heart-failure/
- CICA Life Burial Insurance Review (2026): The B++ Truth & Best-For Verdict: https://theburialinsurance.com/cica-life-burial-insurance-review/
- AIG / Corebridge Financial Life Insurance Review 2026: https://www.insuranceandestates.com/aig-life-insurance-reviews/
- Corebridge Life Insurance Review 2026: Pros, Cons: https://www.lifequotesweb.com/corebridge-life-insurance-review-2026-2/
- Life Insurance For People With a Heart Condition (2026: https://www.moneygeek.com/insurance/life/life-insurance-for-heart-patients/
- Life Insurance for People With a Heart Condition: What You Need to Know: https://www.policygenius.com/life-insurance/heart-conditions/
- Corebridge Financial Life Insurance Review: https://www.riskquoter.com/company-reviews/corebridge-financial/
- Life Insurance with Heart Conditions | Approval & Best Rates: https://www.riskquoter.com/high-risk/heart-conditions/
- Corebridge Financial SEC Filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&company=corebridge&type=10-K&dateb=&owner=include&count=40
- Corebridge Financial Life Insurance (AIG) Review for 2026: https://www.usnews.com/insurance/life-insurance/corebridge-financial
- Corebridge Life Insurance Review 2025: Coverage, Cost and Insights: https://www.wsj.com/buyside/personal-finance/life-insurance/corebridge-financial-life-insurance-review
Additional AI research evidence61 records
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record deepseek:c4
- AI research evidence record deepseek:c5
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record deepseek:c1
- AI research evidence record deepseek:c2
- AI research evidence record deepseek:c3
- AI research evidence record perplexity:c1
- AI research evidence record perplexity:c2
- AI research evidence record perplexity:c10
- AI research evidence record perplexity:c4
- AI research evidence record perplexity:c7
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record deepseek:c1
- AI research evidence record deepseek:c2
- AI research evidence record deepseek:c3
- AI research evidence record perplexity:c1
- AI research evidence record perplexity:c2
- AI research evidence record grok:10
- AI research evidence record kimi:corebridge_site
- AI research evidence record perplexity:c11
- AI research evidence record perplexity:c7
- AI research evidence record perplexity:c10
- AI research evidence record grok:0
- AI research evidence record perplexity:c8
- AI research evidence record perplexity:c9
- AI research evidence record kimi:asurgo_heart
- AI research evidence record kimi:theburialinsurance_chf
- AI research evidence record kimi:cica_review
- AI research evidence record grok:0
- AI research evidence record grok:3
- AI research evidence record perplexity:c4
- AI research evidence record perplexity:c7
- AI research evidence record perplexity:c13
- AI research evidence record grok:2
- AI research evidence record grok:10
- AI research evidence record perplexity:c2
- AI research evidence record kimi:aflac_review
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record openai:c1
- AI research evidence record perplexity:c2
- AI research evidence record perplexity:c9
- AI research evidence record perplexity:c10
- AI research evidence record kimi:theburialinsurance_chf
- AI research evidence record kimi:cica_review
- AI research evidence record perplexity:c2
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record kimi:theburialinsurance_chf
- AI research evidence record kimi:cica_review
- AI research evidence record kimi:fexguy_heart
- AI research evidence record kimi:aflac_review
- AI research evidence record openai:c3
- AI research evidence record perplexity:c4
- AI research evidence record perplexity:c7
- AI research evidence record perplexity:c13
Other Sources
Additional AI research evidence61 records
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record deepseek:c4
- AI research evidence record deepseek:c5
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record deepseek:c1
- AI research evidence record deepseek:c2
- AI research evidence record deepseek:c3
- AI research evidence record perplexity:c1
- AI research evidence record perplexity:c2
- AI research evidence record perplexity:c10
- AI research evidence record perplexity:c4
- AI research evidence record perplexity:c7
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record deepseek:c1
- AI research evidence record deepseek:c2
- AI research evidence record deepseek:c3
- AI research evidence record perplexity:c1
- AI research evidence record perplexity:c2
- AI research evidence record grok:10
- AI research evidence record kimi:corebridge_site
- AI research evidence record perplexity:c11
- AI research evidence record perplexity:c7
- AI research evidence record perplexity:c10
- AI research evidence record grok:0
- AI research evidence record perplexity:c8
- AI research evidence record perplexity:c9
- AI research evidence record kimi:asurgo_heart
- AI research evidence record kimi:theburialinsurance_chf
- AI research evidence record kimi:cica_review
- AI research evidence record grok:0
- AI research evidence record grok:3
- AI research evidence record perplexity:c4
- AI research evidence record perplexity:c7
- AI research evidence record perplexity:c13
- AI research evidence record grok:2
- AI research evidence record grok:10
- AI research evidence record perplexity:c2
- AI research evidence record kimi:aflac_review
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record openai:c1
- AI research evidence record perplexity:c2
- AI research evidence record perplexity:c9
- AI research evidence record perplexity:c10
- AI research evidence record kimi:theburialinsurance_chf
- AI research evidence record kimi:cica_review
- AI research evidence record perplexity:c2
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record kimi:theburialinsurance_chf
- AI research evidence record kimi:cica_review
- AI research evidence record kimi:fexguy_heart
- AI research evidence record kimi:aflac_review
- AI research evidence record openai:c3
- AI research evidence record perplexity:c4
- AI research evidence record perplexity:c7
- AI research evidence record perplexity:c13
Verify this research
Check when the research was run, which platforms were included, and what supports the findings.
- Study date
- September 22, 2026
- Platforms analyzed
- 5
- Source records
- 25
- Ranking mentions
- 2 of 5
- Platform share
- 40%
- Final consensus rank
- #8
Behind the findings
Platforms in this study
- ChatGPT
- Claude
- DeepSeek
- Grok
- Perplexity
- Kimi
- Gemini
Source records
15 independent · 9 company-owned · 1 unclear
Evidence support
16 direct · 9 partial
Keep in mind
Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.
Technical verification details
Use this SHA-256 fingerprint to identify the source snapshot associated with this study.
806e35dc0aff29680d460700e4dedcdb70415ba64851af724c2f9c884c0b4b0f